SCHEMBL11928334

SCHEMBL11928334

CNC(=O)c1ccc2c(C(F)(F)F)cccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 1/20 0.48
▸ HDAC8 Q9BY41 2/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.45
▸ NQO2 P16083 1/20 0.45
▸ PLAU P00749 1/20 0.44
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ NCEH1 Q6PIU2 1/20 0.43
▸ PDK2 Q15119 2/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ PTK2 Q05397 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ ALOX12 P18054 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11245615 0.81 PTPN1 (0.44) HDAC8HDAC6HDAC3HDAC4HDAC1
Fluoride SCHEMBL11245620 0.80 PTPN1 (0.58) —
SCHEMBL27960112 0.77 PLK1 (0.51) PLK1HDAC8HDAC6NQO2PLAU
SCHEMBL21055125 0.73 P4HB (0.46) HDAC8HDAC6PLAUHDAC4HDAC2
SCHEMBL14214022 0.73 KIF11 (0.55) HDAC8HDAC6PLAUHDAC1HDAC2
SCHEMBL13407792 0.73 TAS1R3 (0.59) PLK1HDAC8HDAC6HDAC2PDK2
SCHEMBL13870617 0.73 ADCY8 (0.50) HDAC8HDAC6PLAUHDAC4HDAC1
SCHEMBL761366 0.72 PLAU (0.66) PLK1HDAC8HDAC6PLAUHDAC3
SCHEMBL15628894 0.72 GAA (0.47) PLK1HDAC8HDAC6HDAC3HDAC4
SCHEMBL30369626 0.72 PLAU (0.66) PLK1HDAC8HDAC6PLAUHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695191-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2017-07-04 — — US disclosed
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202821-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS HTR2B, MC1R, HTR1A PLK1 2005/4885HDAC8 3327/4885HDAC6 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback